Lifeward (LFWD) Return on Capital Employed (2016 - 2026)
Lifeward's (LFWD) quarterly Return on Capital Employed came in at 143.57% in Q1 2026, down 896.0% year-on-year from 18.04% in Q1 2025, and up 19.76% quarter-over-quarter from 178.94% in Q4 2025.
Lifeward (LFWD) Return on Capital Employed (2016 - 2026) Analysis & Trends
Lifeward has disclosed Return on Capital Employed across 11 years of filings, most recently posting 143.57% for Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 143.57%, down 896.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 143.57% (down 896.0% YoY), and the FY2025 annual result was 134.25%, down 5410.0% from the prior year.
- Return on Capital Employed came in at 143.57% for Q1 2026 at Lifeward, up from 178.94% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 15.69% in Q1 2022 to a low of 187.09% in Q3 2025.
- The 5-year median for Return on Capital Employed is 52.31% (2024), against an average of 77.11%.
- Across the five-year window, Return on Capital Employed surged 847 bps in 2022 and tumbled 13478 bps in 2025, its largest moves.
- Lifeward's Return on Capital Employed stood at 26.27% in 2022, then plunged by 65 bps to 43.4% in 2023, then plunged by 142 bps to 105.17% in 2024, then sank by 70 bps to 178.94% in 2025, then climbed by 20 bps to 143.57% in 2026.
- The last three Return on Capital Employed figures came in at 143.57% (Q1 2026), 178.94% (Q4 2025), and 187.09% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Lifeward | 11.14 Mn | -263,371.13 | 1.34 Mn | -143.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -143.57% |
| Dec 31, 2025 | -178.94% |
| Sep 30, 2025 | -187.09% |
| Jun 30, 2025 | -171.04% |
| Mar 31, 2025 | -134.61% |
| Dec 31, 2024 | -105.17% |
| Sep 30, 2024 | -52.31% |
| Jun 30, 2024 | -58.02% |
| Mar 31, 2024 | -52.41% |
| Dec 31, 2023 | -43.40% |
| Sep 30, 2023 | -41.10% |
| Jun 30, 2023 | -32.24% |
| Mar 31, 2023 | -28.33% |
| Dec 31, 2022 | -26.27% |
| Sep 30, 2022 | -22.68% |
| Jun 30, 2022 | -18.02% |
| Mar 31, 2022 | -15.69% |
| Dec 31, 2021 | -13.65% |
| Sep 30, 2021 | -14.36% |
| Jun 30, 2021 | -17.43% |